ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 57 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 2.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Group plc | 14,466 | $219,015 | 0.00% |
| MetLife Investment Management, LLC | 11,694 | $177,047 | 0.00% |
| BlackRock Inc. | 1,405,806 | $21,283,903 | 0.00% |
| FMR LLC | 581,937 | $8,810,526 | 0.00% |
| MARSHALL WACE, LLP | 11,312 | $171,264 | 0.00% |
| STRS OHIO | 2,700 | $40 | 0.00% |
| DEUTSCHE BANK AG\ | 8,506 | $128,781 | 0.00% |
| CREDIT SUISSE AG/ | 17,156 | $259,742 | 0.00% |
| CITIGROUP INC | 6,663 | $100,878 | 0.00% |
| GOLDMAN SACHS GROUP INC | 21,336 | $323,031 | 0.00% |
| MORGAN STANLEY | 29,903 | $452,730 | 0.00% |
| Nuveen Asset Management, LLC | 56,814 | $860,164 | 0.00% |
| Bank of New York Mellon Corp | 66,387 | $1,005,099 | 0.00% |
| AMALGAMATED BANK | 2,081 | $32 | 0.00% |
| Tower Research Capital LLC (TRC) | 594 | $8,993 | 0.00% |
| JPMORGAN CHASE & CO | 16,650 | $252,081 | 0.00% |
| BARCLAYS PLC | 6,440 | $97 | 0.00% |
| ROYAL BANK OF CANADA | 2,233 | $34,000 | 0.00% |
| VANGUARD GROUP INC | 1,009,749 | $15,287,599 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 10,874 | $164,632 | 0.00% |
This page lists ENTRADA THERAPEUTICS INC's shareholders in Q2 2023. To view ENTRADA THERAPEUTICS INC's shareholder history, click here.